Joltoo
InvestorsInsights
DeepTech 2026 Playbook
Browse all
  1. Home
  2. /Investors
  3. /Biotech
  4. /Curie.Bio
Curie.Bio

Curie.Bio

Pure DeepTechBoston, United StatesActiveWebsiteLinkedIn
Stage FocusSeed
GeographyUS
TypeAccelerator/VC
Last Activity2025
Industry Focus
Industries
Biotech
Technical BenchStrong
Investor TypeDeepTech Purist
ExposureMostly DeepTech Investments
Bio

Curie.Bio combines a founder-focused seed-stage VC with an industry-grade therapeutics accelerator. Total capital approaches $1B — a $520M initial fund, a $380M Series A fund, and a $340M+ Seed Fund II. Founded by Alexis Borisy, Christoph Lengauer, Tom Hotchkiss, and Zach Weinberg, the firm writes $7-12M seed investments per company.

The 50-person team includes drug hunters and biotech operators,...

Similar Funds

ARCH Venture Partners

ARCH Venture Partners

Chicago, United States

Pure DeepTechBiotechMedTechSynthetic BiologySeedSeries A
Atlas Venture

Atlas Venture

Cambridge, United States

Pure DeepTechBiotechSynthetic BiologyMedTechSeedSeries A
Bold Capital Partners

Bold Capital Partners

Santa Monica, United States

Pure DeepTechBiotechAI InfrastructureMedTechSeedSeries A
Breakout Ventures

Breakout Ventures

San Francisco, United States

Pure DeepTechBiotechSynthetic BiologyClimate TechPre-SeedSeed
Forbion

Forbion

Naarden, Netherlands

Pure DeepTechBiotechSeedSeries A
Longwood Fund

Longwood Fund

Boston, United States

Pure DeepTechBiotechMedTechPre-SeedSeed
Joltoo
Privacy PolicyTerms of Service
© 2026 Joltoo. All rights reserved.